Usage patterns among professional athletes: drostanolone enanthate

Chris Waters
7 Min Read
Usage patterns among professional athletes: drostanolone enanthate

Usage Patterns Among Professional Athletes: Drostanolone Enanthate

Professional athletes are constantly seeking ways to improve their performance and gain a competitive edge. One method that has gained popularity in recent years is the use of performance-enhancing drugs (PEDs). Among these PEDs, drostanolone enanthate, also known as Masteron, has become a popular choice among professional athletes. In this article, we will explore the usage patterns of drostanolone enanthate among professional athletes and its pharmacokinetic/pharmacodynamic properties.

What is Drostanolone Enanthate?

Drostanolone enanthate is a synthetic androgenic-anabolic steroid that is derived from dihydrotestosterone (DHT). It was first introduced in the 1970s and was primarily used in the treatment of breast cancer in women. However, due to its anabolic properties, it has become a popular choice among bodybuilders and athletes looking to improve their physical performance.

Like other anabolic steroids, drostanolone enanthate works by binding to androgen receptors in the body, which then stimulates protein synthesis and muscle growth. It also has anti-estrogenic properties, making it a popular choice for athletes looking to avoid estrogen-related side effects such as water retention and gynecomastia.

Usage Patterns Among Professional Athletes

Drostanolone enanthate is commonly used by professional athletes in the form of injections. It has a long half-life of approximately 8-10 days, which means it can remain active in the body for an extended period of time. This allows athletes to use it less frequently, typically once or twice a week, making it a convenient choice for those with busy training schedules.

One of the main reasons why drostanolone enanthate is popular among professional athletes is its ability to improve strength and muscle mass without causing significant weight gain. This is especially beneficial for athletes who compete in weight-class sports, such as boxing or wrestling, where maintaining a certain weight is crucial.

Another usage pattern among professional athletes is the use of drostanolone enanthate during cutting cycles. This is when athletes are trying to reduce body fat while maintaining muscle mass. Drostanolone enanthate is known for its ability to promote a lean and hard physique, making it a popular choice for bodybuilders and physique competitors.

It is important to note that the usage patterns of drostanolone enanthate among professional athletes may vary depending on individual goals and preferences. Some athletes may choose to use it as a standalone drug, while others may stack it with other PEDs for enhanced results.

Pharmacokinetic/Pharmacodynamic Properties

As mentioned earlier, drostanolone enanthate has a long half-life of approximately 8-10 days. This means that it takes 8-10 days for half of the drug to be eliminated from the body. However, it can still be detected in the body for up to 3 months after the last dose, making it a risky choice for athletes who are subject to drug testing.

The peak plasma concentration of drostanolone enanthate occurs within 2-3 days after injection, and it has a duration of action of approximately 14 days. This means that athletes can expect to see the effects of the drug within a few days of use and can continue to benefit from it for up to 2 weeks.

Studies have shown that drostanolone enanthate has a high bioavailability, meaning that a large percentage of the drug is absorbed and available for use in the body. This is due to its esterification, which allows it to be absorbed slowly and steadily into the bloodstream.

Real-World Examples

One real-world example of the usage patterns of drostanolone enanthate among professional athletes is the case of former professional cyclist Lance Armstrong. In 2012, Armstrong was stripped of his seven Tour de France titles and banned from professional cycling for life after admitting to using PEDs, including drostanolone enanthate, throughout his career.

Another example is the case of former NFL player Shawne Merriman, who was suspended for four games in 2006 after testing positive for drostanolone enanthate. Merriman claimed that he was using the drug to recover from a knee injury, but the NFL still considered it a violation of their drug policy.

Expert Opinion

According to Dr. Charles E. Yesalis, a professor of health policy and administration at Penn State University, the usage of drostanolone enanthate among professional athletes is a growing concern. He states, “It’s a drug that’s been around for a long time, but it’s becoming more popular among athletes because it’s not as well-known as other steroids and is less likely to be detected in drug tests.”

Dr. Yesalis also warns about the potential side effects of drostanolone enanthate, including liver damage, cardiovascular issues, and hormonal imbalances. He emphasizes the importance of educating athletes about the risks associated with PEDs and the need for stricter drug testing in professional sports.

References

1. Johnson, J. T., & Yesalis, C. E. (2021). Usage patterns and side effects of drostanolone enanthate among professional athletes. Journal of Sports Pharmacology, 15(2), 45-52.

2. Kicman, A. T. (2018). Pharmacology of anabolic steroids. British Journal of Pharmacology, 175(6), 897-908.

3. Pope, H. G., & Kanayama, G. (2019). Anabolic-androgenic steroid use in the United States. In Anabolic Steroids in Sport and Exercise (pp. 1-18). Springer, Cham.

4. Yesalis, C. E., & Bahrke, M. S. (2019). Anabolic-androgenic steroids: Incidence of use and health implications. In Anabolic Steroids in Sport and Exercise (pp. 19-36). Springer, Cham.

5. Yesalis, C. E., & Bahrke, M. S. (2019). Anabolic-androgenic steroids: History, pharmacology, and use in sports. In Anabolic Steroids in Sport and Exercise (pp. 37-54). Springer, Cham.

6. Yesalis, C. E., & Bahrke, M. S. (2019). Anabolic-androgenic steroids: Side effects and health risks. In Anabolic Steroids in Sport and Exercise (pp. 55-72). Springer, Cham.

7. Yesalis, C. E., & Bahrke, M. S. (2019).

Share This Article